Featured Research

from universities, journals, and other organizations

Breast Cancer Drug May Protect The Heart, Too

Date:
February 20, 2001
Source:
American Heart Association
Summary:
The breast cancer drug tamoxifen was shown to reduce levels of key inflammatory markers that have been linked to an increased risk of heart disease, researchers report in this month’s Arteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association.

DALLAS, Feb. 9 – The breast cancer drug tamoxifen was shown to reduce levels of key inflammatory markers that have been linked to an increased risk of heart disease, researchers report in this month’s Arteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association.

Related Articles


Tamoxifen is in a class of drugs known as selective estrogen receptor modulators (SERMs). The drug has been shown to reduce the incidence of breast cancer in healthy women at high risk of developing that disease.

Similar to postmenopausal hormone therapy, tamoxifen was predicted to reduce cardiovascular risk on the basis of its cholesterol-lowering properties.

In this study, tamoxifen was shown to reduce levels of C-reactive protein (CRP) by 26 percent, and to reduce fibrinogen levels by 22 percent. CRP is a marker for low-grade inflammation. Fibrinogen is a blood coagulation factor and is also a marker of inflammation. High levels of these inflammatory markers have been associated with increased risk for cardiovascular disease in several studies, says Mary Cushman, M.D., M.Sc., lead author of the paper and assistant professor of medicine at the University of Vermont in Burlington.

“Tamoxifen has mixed effects depending on the organ it’s acting on. Therefore, it’s important to determine the drug’s effects on other organs such as the heart and blood vessels, because cardiovascular disease is much more common than breast cancer,” says Cushman on why the research group investigated the cardiovascular effects of tamoxifen. Heart disease is the number one killer of American women.

Previous breast cancer trials have reported 15 percent to 60 percent reductions in cardiac death in women treated with tamoxifen, and researchers linked this effect to the drug’s lipid-lowering properties. Indeed, women on tamoxifen had a 9 percent reduction in total cholesterol levels in this study. However, Cushman reports that the effects on inflammatory markers were larger than on cholesterol.

The study participants were a group of 111 healthy women who were participating in a breast cancer prevention trial called the National Surgical Adjuvant Breast and Bowel Program P-1 trial. The women were age 58 on average and most were postmenopausal. Thirteen of them had two or more risk factors for cardiovascular disease. Every day for six months, 51 women took 20 mg tamoxifen pills, and 60 took a placebo pill. At the end of the study, the research team compared CRP, fibrinogen and cholesterol levels between the tamoxifen and placebo groups.

In the placebo group, fibrinogen and CRP levels did not change significantly from the beginning to the end of the study. In contrast, the tamoxifen group had a 0.64 grams per liter (g/L) decline in fibrinogen levels and a 0.30 mg/L drop in CRP levels.

In a subset of participants who were followed for an additional 18 months, those on tamoxifen still had significantly lower levels of these factors.

Cushman says further research is needed to confirm these findings, and calls for a larger study to investigate the specific effects of tamoxifen on cardiovascular disease risk.

Co-authors include Joseph P. Costantino, Ph.D.; Russell P. Tracy, Ph.D.; Kyunghee Song, Ph.D.; Lenore Buckley, M.D.; John D. Roberts, M.D.; and David N. Krag, M.D.


Story Source:

The above story is based on materials provided by American Heart Association. Note: Materials may be edited for content and length.


Cite This Page:

American Heart Association. "Breast Cancer Drug May Protect The Heart, Too." ScienceDaily. ScienceDaily, 20 February 2001. <www.sciencedaily.com/releases/2001/02/010213070845.htm>.
American Heart Association. (2001, February 20). Breast Cancer Drug May Protect The Heart, Too. ScienceDaily. Retrieved October 26, 2014 from www.sciencedaily.com/releases/2001/02/010213070845.htm
American Heart Association. "Breast Cancer Drug May Protect The Heart, Too." ScienceDaily. www.sciencedaily.com/releases/2001/02/010213070845.htm (accessed October 26, 2014).

Share This



More Health & Medicine News

Sunday, October 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
Toxin-Packed Stem Cells Used To Kill Cancer

Toxin-Packed Stem Cells Used To Kill Cancer

Newsy (Oct. 25, 2014) — A Harvard University Research Team created genetically engineered stem cells that are able to kill cancer cells, while leaving other cells unharmed. Video provided by Newsy
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins